Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

Lung cancer remains the leading cause of cancer deaths in Virginia, according to a new report from the American Lung Association. The 2025 “State of Lung Cancer” report for Virginia found in most ...

Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of actionable mutations. Biomarker testing for patients with lung cancer is critical, ...

About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in ...

Lung cancer in never-smokers challenges lifestyle-based assumptions and underscores the need to address stigma that can delay evaluation and psychosocial support. Subtle, prolonged respiratory or ...

Desai, MBBS, MD, assistant professor of thoracic medical oncology/head and neck medical oncology at Fox Chase Cancer Center ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 ...

Although treatment of advanced gastroesophageal cancer is increasingly dependent on biomarkers, only about 40% of patients are tested. For patients to fully benefit from the latest targeted therapies, ...

SAN FRANCISCO, CA, UNITED STATES, January 8, 2026 /EINPresswire.com/ — New global initiative urges patients and clinicians to wait for biomarker testing results ...

It’s common to wait until something feels “off” before making an appointment to see a healthcare provider. But waiting for noticeable symptoms can mean missing the chance to catch health issues early.

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment. SAN FRANCISCO, CA, UNITED STATES, January 8, 2026 ...